Stay updated on Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The study locations list now includes Taebuk, Chungcheongbuk-do, South Korea (28644) and previously listed Jungbuk (28644) was removed; the page revision was updated from v3.5.3 to v3.5.4.
    Difference
    0.0%
    Check dated 2026-05-19T23:08:52.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    27 days ago
    Change Detected
    Summary
    The revision tag has been updated to v3.5.3, replacing the previous v3.5.0 in the revision history. This represents a metadata update with no substantive changes to the study details.
    Difference
    0.0%
    Check dated 2026-04-28T10:46:09.000Z thumbnail image
  4. Check
    49 days ago
    Change Detected
    Summary
    The Veneto, Italy site listing changed from Padua to Padova (postal code 35128).
    Difference
    0.0%
    Check dated 2026-04-06T03:10:48.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    A new publication citation has been added to the Publications section: 'Assessing side-effect bother, burden, and tolerability: A qualitative study exploring the content validity of the Functional Assessment of Cancer Therapy - Item GP5.' This reference provides additional context for the study's reported outcomes but does not modify study design or participant information.
    Difference
    0.0%
    Check dated 2026-03-30T01:57:07.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Napoli, Campania, Italy, 80131 was renamed to Naples, Campania, Italy, 80131 and a Naples listing was added, with the page revision updated to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-22T21:21:45.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3; removed Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-08T04:41:08.000Z thumbnail image

Stay in the know with updates to Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial page.